title: Fatal Case of Recurrent Takotsubo Cardiomyopathy Presenting with Cardiac Arrest and Variable Ventricular Involvement What Role Beta Agonist and Beta Blockers?
abstract: In conclusion, we believe that the demise of the patient is due to the combination of severe emotional distress, respiratory distress with fear of impending doom, and the overuse of B2 agonists likely created an opportune environment for Takotsubo cardiomyopathy. We also propose a mechanism whereby recurrences with different wall motion variants may occur during beta blocker therapy.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Sharrett
authors.forename: Satish
authors.initials: S
authors.lastname: Surabhi
authors.forename: Scott
authors.initials: S
authors.lastname: Philips
authors.forename: Harold
authors.initials: H
authors.lastname: Morse
mesh_terms: D000318:Adrenergic beta-Agonists / Q000009:adverse effects*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006323:Heart Arrest; D006801:Humans; D008875:Middle Aged; D063487:Prescription Drug Misuse; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012008:Recurrence; D012770:Shock, Cardiogenic / Q000139:chemically induced*; D054549:Takotsubo Cardiomyopathy / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists